Real estate investment trusts have drawn renewed attention as interest-rate outlooks and demographic trends continue to influence the sector. In this environment, REET and REZ often come up in discussions, though they are not interchangeable. Each offers a distinct way to gain real estate exposure. REET provides wide global coverage across multiple property types, while REZ narrows in on U.S. residential, healthcare, and self-storage areas. I find it useful to examine their structural differences before deciding how either might fit an allocation.
REET aims to follow the FTSE EPRA Nareit Global REIT Index, which includes listed REITs and real estate companies from developed and emerging markets. The fund is passively managed, holds around 350 securities, and oversees roughly $4.6 billion in assets. Its expense ratio stands at 0.14%. Top holdings include WELL, PLD, EQIX, SPG, and DLR. Sector exposure spans retail, industrial, healthcare, data centers, multifamily, office, and self-storage, with the United States making up about 70% of the portfolio and additional weight in Australia, Japan, the United Kingdom, and Singapore. This setup supports a core diversified real estate position with limited concentration in any single country or property type. I also checked this using Tickeron’s AI Screener to see how the holdings compare across regions.
REZ follows the FTSE Nareit All Residential Capped Index, covering U.S. residential, healthcare, and self-storage equities. It holds approximately 40 securities and manages about $800 million in assets. The expense ratio is 0.48%. Welltower (WELL) represents roughly 23% of the fund, with other notable positions including PSA, VTR, EXR, AVB, and EQR. Healthcare REITs account for nearly half the assets, followed by residential and specialized names. This focused, U.S.-only construction positions REZ as a more tactical choice for those with specific views on senior housing and apartments rather than a broad core holding.
Both funds sit within a real estate landscape shaped by aging demographics that support senior housing operators like Welltower and Ventas, a dynamic that aligns closely with REZ’s healthcare emphasis. Housing affordability pressures also sustain demand for rental apartments. REET captures these elements while incorporating industrial logistics, data centers, and retail, where e-commerce and AI-related infrastructure spending play roles. Interest-rate expectations remain the key macro driver, as REITs respond to financing costs and compete with bonds for yield. A higher-for-longer environment has weighed on valuations, whereas easing could provide broader support. From what I see, these crosscurrents matter when weighing the two funds’ positioning.
REZ’s concentrated tilt toward healthcare and residential names has helped it capture recent momentum in senior housing and apartments tied to demographic trends. That same concentration, however, ties performance closely to a limited set of holdings, especially Welltower. REET has benefited from broader recovery through industrial, data center, and retail exposure, with international holdings offering some buffer against U.S.-specific slowdowns. It generally shows lower single-stock volatility and more even sector performance, though it may trail when REZ’s targeted areas lead. Overall, REET emphasizes breadth and resilience, while REZ provides higher conviction at the cost of greater concentration risk.
When evaluating options like these, I often rely on Tickeron’s AI Screener to filter ETFs by technical patterns, fundamentals, and performance metrics. It surfaces data-driven comparisons that help clarify structural differences and support more informed allocation decisions without requiring hours of manual work.
Based on structural strength, cost efficiency, diversification, and risk exposure, Tickeron’s AI currently favors REET over REZ. The 0.14% expense ratio, roughly 350 holdings, and global reach deliver a lower-cost, more diversified vehicle, with added balance from industrial, data center, and retail exposure. REZ offers a higher-conviction approach to healthcare and residential real estate with notable momentum, yet the 23% weight in one issuer and 0.48% fee increase concentration risk. The verdict therefore points to REET as the more efficient and balanced choice for most investors, while recognizing REZ as a tactical option for those seeking concentrated subsector exposure.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for REZ turned positive on October 12, 2026. Looking at past instances where REZ's MACD turned positive, the stock continued to rise in 46 of 51 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on REZ as a result. In 66 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
REZ moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for REZ crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 21 of 25 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 84%.
Following a +3.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where REZ advanced for three days, in 267 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where REZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
REZ broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for REZ entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category RealEstate